The U.K.’s promotional police cracked down on biosimilar marketing this week, citing Pfizer’s Hospira unit and Napp Pharmaceuticals for code violations at…

After a former Insys Therapeutics sales rep admitted she had paid kickbacks to doctors to prescribe the company's sprayed cancer pain opioid fentanyl for…

Novartis is getting closer to unloading its $14 billion stake in crosstown rival Roche. Big investors have been shopping the sale, and bankers could assemble…

Chairman Zhou Jie resigns just three months after taking on the role.

A California whistleblower case against Celgene has moved forward with the unsealing of thousands of pages of new documents that attorneys for a former sales…

The power of a Hillary Clinton tweet showed again Wednesday, when the presidential candidate spoke on drug price, raising fears of government action. Biotech…

Amid a frenzy of criticism for the price of EpiPen, Mylan swiftly expanded its co-pay help for patients. But it did not adjust the actual price of a med that’s…

BeiGene has been cleared to start Chinese trials of its PARP inhibitor BGB-290, one of a portfolio of homegrown drugs that aims to challenge Western dominance…